NSEChange in Management6d ago · 14 Aug 2026, 05:09 pm
Change in Management
Rubicon Research Limited · RUBICON
✦ AI SummaryMgmt Change
Rubicon Research Limited has informed the Exchange about change in Management, with the Board of Directors approving the appointment of Mr. Rohit Saraogi as Chief Financial Officer (CFO) and the re-appointment of Mr. Venkat Changavalli as Chairman, effective from September 18, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rubicon Research Limited has informed the Exchange about change in Management
Attachments (1)
📄pdf
Download →
9823522970_14082026170850_SEIntimationOutcomeVCSM14082026.pdf
View document text
Date: August 14, 2026
To, To,
BSE Limited National Stock Exchange of India Limited
Listing Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor, Plot no. C/1, G Block
Dalal Street – Fort Bandra Kurla Complex, Bandra (East),
Mumbai 400 001 Mumbai - 400 051
Scrip Code: 544578 NSE Symbol: RUBICON
ISIN: INE506V01022
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘SEBI Listing Regulations’) – Outcome of the Board Meeting.
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the
Company at its meeting held today i.e., on August 14, 2026, has inter alia, considered and approved the
following:
1. Appointment of Senior Management Personnel and CFO Leadership Transition
Appointment of Mr. Rohit Saraogi, Chief Financial Officer (“CFO”) - Designate, as a Senior Management
Personnel of the Company, effective August 14, 2026.
Mr. Nitin Jajodia, the current CFO and Key Managerial Personnel (“KMP”) of the Company, will, upon
recommendation of the Nomination and Remuneration Committee and the Audit Committee, move to an
operating/business role as Chief Commercial Officer (“CCO”). Concurrently, Mr. Rohit Saraogi will assume
charge as CFO and KMP of the Company, subject to receipt of such other approvals as may be necessary.
This appointment and the related transition are a significant step as the Company prepares for its new phase of
growth in the coming years.
Note: The approval of the Board of Directors will be separately obtained in respect of the effective date of the
change in KMP, subject to such other approvals as may be required.
Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744
Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India
+91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in
2. Re-appointment and Extension of Tenure of the Chairman
Re-appointment and extension of the term of Mr. Venkat Changavalli as the Chairman of the Company, effective
from September 18, 2026, to June 10, 2027 (co-terminus with the completion of his first term as an Independent
Director).
Details as required under SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure – A.
The Meeting of the Board of Directors of the Company commenced at 03:00 PM (IST) and concluded at 04:15
PM (IST).
Kindly take the above information on record.
Thanking you,
Yours faithfully,
For Rubicon Research Limited
Deepashree Tanksale
Company Secretary
M. No. A28132
Encl.: As above
Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744
Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India
+91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in
Annexure – A
S. No. Particulars Mr. Rohit Saraogi Mr. Venkat Changavalli
1. Reason for change viz. Appointment of Mr. Rohit Saraogi, Re-appointment and extension of the
appointment, Chief Financial Officer (“CFO”) - term of Mr. Venkat Changavalli as the
resignation, removal, Designate, as a Senior Management Chairman of the Company, effective
death or otherwise Personnel of the Company, from September 18, 2026, to June 10,
2. Date of appointment/ effective August 14, 2026. 2027 (co-terminus with the
resignation & term of Term of Appointment: As per completion of his first term as an
appointment. Policy of the Company Independent Director).
3. Brief profile (in case of Mr. Rohit Saraogi is a passionate Mr. Venkat Changavalli serves as the
appointment) financial professional with over 24 Chairman and Independent Director
years of experience spanning on the Board of the Company. He
leading multinational corporations holds a bachelor’s degree in
and Indian promoter led technology from Jawaharlal Nehru
enterprises, including Vini Technological University, Andhra
Cosmetics, S H Kelkar & Co, Bajaj Pradesh (1976), and a Post Graduate
Consumer Care, Diageo, Marico, Diploma in Management from the
Reckitt Benckiser, and Coca Cola. A Indian Institute of Management
qualified Chartered Accountant and (IIM), Ahmedabad (1977).
Company Secretary, he brings Mr. Changavalli brings industry
expertise across commercial and expertise and professional
business finance, cross border experience in the pharmaceutical
M&A, capital allocation, global sector.
treasury, investor relations, and
large-scale digital finance Detailed profile is available at the
transformations in both FMCG/B2C website of the Company at
and B2B sectors. www.rubicon.co.in.
4. Disclosure of Not Applicable None
relationships between
directors (in case of
appointment of a
director)
5 Information as Not Applicable Mr. Venkat Changavalli is not
required pursuant to debarred from continuing the office
Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744
Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India
+91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in
BSE circular with ref. of Chairman and Independent
no. LIST/ COMP/ 14/ Director by virtue of any SEBI order or
2018- 19 dated June any other such authority.
20, 2018, and the NSE
circular ref. no. NSE/
CML/ 2018/24 dated
June 20, 2018.
For Rubicon Research Limited
Deepashree Tanksale
Company Secretary
M. No. A28132
Encl.: As above
Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744
Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India
+91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in